Trial Profile
Escalation Study of BTP-114 in Patients With Advanced Solid Tumors and BRCA or DNA Repair Mutation
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs BTP 114 (Primary)
- Indications Advanced breast cancer; Breast cancer; Ovarian cancer; Pancreatic cancer; Prostate cancer; Solid tumours; Triple negative breast cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Placon Therapeutics
- 11 Jan 2019 Status changed from recruiting to active, no longer recruiting.
- 28 Oct 2016 Status changed from planning to recruiting.
- 30 Mar 2016 New trial record